Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid-Organ Transplantation

De novo Therapy with Everolimus, Low-Dose Ciclosporine A, Basiliximab and Steroid Elimination in Pediatric Kidney Transplantation

(2010) L. Pape et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Human cytomegalovirus-specific CD4+ and CD8+ T-cell response determination: Comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host

(2010) Paola Zelini et al.   CLINICAL IMMUNOLOGY

Evaluation of Cytomegalovirus (CMV)–Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV‐Specific T Cell Reconstitution in Kidney Transplant Recipients

(2010) Davide Abate et al.   JOURNAL OF INFECTIOUS DISEASES

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

(2010) Camille N. Kotton et al.   TRANSPLANTATION

Preemptive Therapy for Systemic and Pulmonary Human Cytomegalovirus Infection in Lung Transplant Recipients

(2009) G. Gerna et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil inde novocardiac transplant recipients: a randomized, multicenter study

(2009) M. Viganò et al.   Transplant Infectious Disease